featured
Maintenance With Panitumumab Alone vs Panitumumab + Fluorouracil–Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial
JAMA Oncol 2019 Jul 03;[EPub Ahead of Print], F Pietrantonio, F Morano, S Corallo, R Miceli, S Lonardi, A Raimondi, C Cremolini, L Rimassa, F Bergamo, A Sartore-Bianchi, M Tampellini, P Racca, M Clavarezza, R Berenato, M Caporale, M Antista, M Niger, V Smiroldo, R Murialdo, A Zaniboni, V Adamo, G Tomasello, M Giordano, F Petrelli, R Longarini, S Cinieri, A Falcone, V Zagonel, M Di Bartolomeo, F de BraudFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.